Serum Cystatin C and the Incidence of Hypertension in Type 1 Diabetes Mellitus | Zendy

Karine Sahakyan | Zendy; Barbara E.K. Klein | Zendy; K. E. Lee | Zendy; Michael Y. Tsai | Zendy; Ronald Klein | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum Cystatin C and the Incidence of Hypertension in Type 1 Diabetes Mellitus

Author(s) -

Karine Sahakyan,

Barbara E.K. Klein,

K. E. Lee,

Michael Y. Tsai,

Ronald Klein

Publication year - 2010

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1038/ajh.2010.215

Subject(s) - medicine , incidence (geometry) , cystatin c , diabetes mellitus , hazard ratio , blood pressure , body mass index , cumulative incidence , type 2 diabetes mellitus , type 2 diabetes , endocrinology , confidence interval , renal function , cardiology , cohort , physics , optics

Serum cystatin has been shown to be associated with hypertension in the general population. Little is known on the relationship of serum cystatin C with the long-term hypertension incidence in persons with diabetes. We examined the association of serum cystatin C with the incidence of hypertension over a 15-year period in people with type 1 diabetes mellitus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research